Official Fee Schedule for Licences and Registration in Macao
Updated: 2026-11-11 · GRZAN Regulatory Team · Verification date 2026-10-20
1. Key takeaways
The official fees of the medical device regime in Macao, China are set out in the Fee Schedule for Medical Device Business Activities and Medical Device Registration approved by Dispatch of the Chief Executive No. 144/2026 (published on 15 June 2026 in Official Gazette No. 24/2026, effective on 1 July 2026). The schedule is organised in two blocks: licences for medical device business activities (manufacturing licence MOP 9,000, renewal MOP 3,000; business licence MOP 2,000, renewal MOP 300; contract manufacturing permit MOP 500, renewal MOP 200) and medical device registration (registration MOP 500, renewal MOP 200, reissue of the registration certificate MOP 200).
- All official fees are contained in one dispatch, effective from 1 July 2026.
- Licence fees range from MOP 500 to MOP 9,000 at first issue.
- Registration costs MOP 500, with renewal and certificate reissue at MOP 200 each.
- Official fees are a small fraction of the total cost of market access.
- Whether filing carries a separate fee item is pending verification against the official payment notices.
2. Legal basis
The fee schedule is anchored in the Chief Executive dispatch, and its application connects to the licence, registration and renewal provisions of the parent law, the implementing rules and the renewal dispatch. The table below lists the instruments relied on in this article.
| Regulatory instrument | Reference | Publication date | Provisions |
| Dispatch of the Chief Executive No. 144/2026 approving the Fee Schedule for Medical Device Business Activities and Medical Device Registration | Dispatch of the Chief Executive No. 144/2026 (Official Gazette No. 24/2026) | Published on 15 June 2026; effective on 1 July 2026 | Full text of the dispatch; Table 1 (licences for medical device business activities); Table 2 (medical device registration) |
| Medical Devices Regulatory Regime | Law No. 12/2025 (Official Gazette No. 30/2025) | Published on 28 July 2025; effective on 1 July 2026 | Article 31 (categories of licences); Article 32 (manufacturing licence); Article 33 (validity of the licence); Article 36 (contract manufacturing) |
| Implementing Rules of the Medical Devices Regulatory Regime | Administrative Regulation No. 11/2026 (Official Gazette No. 20/2026) | Published on 18 May 2026; effective on 1 July 2026 | Application provisions for the manufacturing licence, the business licence and the contract manufacturing permit; provisions on registration applications and renewal; article on reissue of certificates |
| Technical Requirements and Specific Rules for Renewal of Medical Device Registration | Dispatch No. 10/ISAF/2026 | Published in 2026; effective on 1 July 2026 | Full text of the dispatch |
3. Expert insights
Insight one: official fees are a tiny share of total cost; the real cost lies in compliance preparation. The registration fee for a Class III device is only MOP 500, and the manufacturing licence MOP 9,000 — extremely low levels compared with the Chinese mainland and the European Union. The purpose of this schedule is threshold confirmation, not budgeting — the real expenditure of companies lies in obtaining proof of overseas marketing, test reports, clinical evaluation, GMP system documentation and localised labelling. In its quotations, GRZAN often meets clients who assume that low official fees mean a low total cost; this is the first point that needs to be clarified.
Insight two: renewal fees are generally 20 to 40 per cent of the first issue fee, with the business licence the only outlier. The manufacturing licence runs from 9,000 to 3,000 (about 33 per cent), registration from 500 to 200 (40 per cent), and the contract manufacturing permit from 500 to 200 (40 per cent), while the business licence runs from 2,000 to 300 (15 per cent). This structure shows that the legislator deliberately kept the cost of market entry for the distribution stage low, so that distribution and retail networks can expand quickly, with regulatory weight placed on manufacturing and on the products themselves.
Insight three: the reissue of a certificate is listed separately at MOP 200, the same as renewal. Where a registration certificate is damaged or lost and must be reissued, the fee is MOP 200. This item is often overlooked, yet the probability of loss is not low for cross-border entities in certificate circulation, bank account opening and customs filing scenarios; companies are advised to write reissue handling into their internal certificate management system.
Insight four: the fee schedule is separate from ex officio procedures. Inspections, investigations and sampling tests carried out by the ISAF on its own initiative are a different category of acts from licences, registrations and permits issued upon application. The fee schedule targets acts performed upon application; companies should not budget on the assumption that inspections must be paid for, and conversely should not expect that paying fees will accelerate the review.
Insight five: whether filing carries a separate fee item must be confirmed against the official text of the schedule. Law No. 12/2025 places Class I and Class IIa devices on the filing channel and Class IIb and Class III devices on the registration channel. Practical estimate: at the time of verification by GRZAN, the schedule lists items under the two headings of licences for medical device business activities and medical device registration; whether filing is listed as a separate fee item is subject to the payment notices published by the ISAF (pending verification); when budgeting, companies are advised to reserve zero or a low amount, and to reserve administrative time for handling the payment notice.
4. Practical recommendations
- Budget official fees separately from compliance service costs: official fees are in the hundreds to a few thousand Macao patacas, while compliance preparation is the main expenditure.
- Run a five-year full-cycle calculation on the basis of one application plus one renewal: registration, with a 5-year validity, corresponds to 500 plus 200; the manufacturing licence, with a 3-year validity, corresponds to 9,000 plus 3,000.
- Write the certificate reissue procedure into the certificate management system: define the responsible person, the storage method and the reissue application path (MOP 200).
- Follow the payment notice of the ISAF: amounts and items are governed by the official notice, not by historical experience or the experience of others.
5. Verification checklist
- □ Official text of the fee schedule in Dispatch of the Chief Executive No. 144/2026 obtained
- □ Manufacturing licence 9,000 and renewal 3,000 MOP included in the budget
- □ Business licence 2,000 and renewal 300 MOP included in the budget
- □ Registration 500, renewal 200 and certificate reissue 200 MOP included in the budget
- □ Contract manufacturing permit 500 and renewal 200 MOP included in the budget
- □ Fee treatment of filing confirmed with the ISAF
- □ Number of renewals within the 5-year and 3-year cycles calculated
- □ Payment method and rules for keeping payment receipts defined
Regulatory information verified as of 29 October 2026. The laws, guidelines and effective dates described in this article are limited to the content published by the official sources listed under Legal basis as of that date; where official documents are updated, the most recently published version prevails.
How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for Macao, China. Our team coordinates local licence holder arrangements, import and supply requirements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com
Disclaimer
Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.
About GRZAN
GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.
GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.
Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.
What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.
Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.
Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.
Take your devices global with GRZAN
We work with manufacturers worldwide to open new markets with a clear regulatory pathway.
Contact us